How Is Receptor Activator of Nuclear Factor-κβ/Receptor Activator of Nuclear Factor-κβ Ligand Targeting Ranked as an Immuno-Oncology Target for NSCLC: a Pathway Unclear as yet?

被引：0
|
作者：
Chu, Quincy S. C. [1 ]
机构：
[1] Univ Alberta, Cross Canc Inst, 11560 Univ Ave, Edmonton, AB T6G 1Z2, Canada
来源：
JOURNAL OF THORACIC ONCOLOGY | 2020年 / 15卷 / 10期
关键词：
ZOLEDRONIC ACID; LUNG-CANCER; MULTIPLE-MYELOMA; TUMOR-GROWTH; DENOSUMAB; CELLS; PROMOTES; TUMORIGENESIS; METASTASIS; MIGRATION;
D O I：
10.1016/j.jtho.2020.07.011
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1561 / 1564
页数：4
相关论文
共 50 条
  • [1] Receptor activator of nuclear factor-κB ligand activates nuclear factor-κB in osteoclast precursors
    Wei, S
    Teitelbaum, SL
    Wang, MWH
    Ross, FP
    ENDOCRINOLOGY, 2001, 142 (03) : 1290 - 1295
  • [2] Antibodies to receptor activator of nuclear factor-κ B ligand (RANKL)
    Terpos, Evangelos
    Christoulas, Dimitrios
    Dimopoulos, Meletios-Athanassios
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2008, 18 (11) : 1265 - 1269
  • [3] The Effect of Osteoprotegerin (OPG)/Receptor Activator of Nuclear Factor-κB Ligand (RANKL)/Receptor Activator of Nuclear Factor-κB (RANK) on Aortic Valve Calcified
    Luo, Wei
    Wang, Jing
    Yang, Xia
    Li, Junshan
    Song, Yanqiu
    Cong, Hongliang
    ANNALS OF CLINICAL AND LABORATORY SCIENCE, 2024, 54 (05): : 633 - 642
  • [4] Differential expression of periostin, sclerostin, receptor activator of nuclear factor-κB, and receptor activator of nuclear factor-κB ligand genes in severe chronic periodontitis
    Sankardas, Pooja A.
    Lavu, Vamsi
    Lakakula, Bhaskar V. K. S.
    Rao, Suresh R.
    JOURNAL OF INVESTIGATIVE AND CLINICAL DENTISTRY, 2019, 10 (01) : e12369
  • [5] The Effect of Osteoprotectin (OPG)/Receptor Activator of Nuclear Factor-κB Ligand (RANKL)/Receptor Activator of Nuclear Factor-κB (RANK) Gene Methylation on Aortic Valve Calcified
    Luo, Wei
    Song, Yanqiu
    Wang, Jing
    Yang, Xia
    Li, Zuocheng
    Cong, Hongliang
    BIOMED RESEARCH INTERNATIONAL, 2022, 2022
  • [6] Targeting the receptor activator of nuclear factor-κB (RANK) ligand in prostate cancer bone metastases
    Saad, Fred
    Markus, Richard
    Goessl, Carsten
    BJU INTERNATIONAL, 2008, 101 (09) : 1071 - 1075
  • [7] Soluble receptor activator of nuclear factor-κB ligand and risk for cardiovascular disease
    Kiechl, Stefan
    Schett, Georg
    Schwaiger, Judith
    Seppi, Klaus
    Eder, Paula
    Egger, Georg
    Santer, Peter
    Mayr, Agnes
    Xu, Qingbo
    Willeit, Johann
    CIRCULATION, 2007, 116 (04) : 385 - 391
  • [8] Guggulsterone Inhibits Osteoclastogenesis Induced by Receptor Activator of Nuclear Factor-κB Ligand and by Tumor Cells by Suppressing Nuclear Factor-κB Activation
    不详
    CLINICAL CANCER RESEARCH, 2018, 24 (17) : 4347 - 4347
  • [9] Role of receptor activator of nuclear factor-κB ligand and osteoprotegerin in bone cell biology
    Lorenz C. Hofbauer
    Armin E. Heufelder
    Journal of Molecular Medicine, 2001, 79 : 243 - 253
  • [10] Osteoprotegerin and receptor activator of nuclear factor-κB ligand (RANKL) in the serum of healthy adults
    Jung, K
    Lein, M
    Von Hösslin, K
    Grosse, A
    Roth, S
    Possinger, K
    Lüftner, D
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2002, 17 (03): : 177 - 181
12345